Bioventus Inc.

10.13
-0.01 (-0.10%)
At close: Mar 03, 2025, 3:59 PM
9.65
-4.79%
After-hours: Mar 03, 2025, 07:22 PM EST

Bioventus Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY15 FY14 FY13
Net Income -121.2M -213.39M 9.59M 14.72M 8.11M 4.44M -34.11M -12.9M -22.37M
Depreciation & Amortization 57.37M 66.8M 34.88M 28.64M 30.32M 29.24M 33.08M 28.82M 24.46M
Stock-Based Compensation 2.72M 17.59M 19.84M 10.1M 10.84M 14.32M 3.33M 2.35M 576K
Other Working Capital -13.24M 22.1M -14.62M -733K -3.88M -422K 1.17M -25.48M 1.33M
Other Non-Cash Items 82.01M 182.79M 6.08M 3.53M 5.36M -5.59M 20.35M 6.35M 11.86M
Deferred Income Tax -2.38M -52.79M -9.76M -511K -348K -79K -432K -701K -475K
Change in Working Capital -3.18M -14.53M -13.28M 15.31M -13.57M 2.85M -10.65M -12.01M -16.41M
Operating Cash Flow 15.34M -13.54M 22.99M 71.8M 40.71M 45.19M 18.92M 15.11M 2.75M
Capital Expenditures -7.36M -11.52M -7.37M -20.67M -8.34M -6.06M -7.44M -20.83M -6.36M
Acquisitions 34.67M -104.84M -262.87M n/a 430K n/a -51.46M -10.55M n/a
Purchase of Investments n/a n/a -13.52M n/a n/a n/a -941K n/a n/a
Sales Maturities Of Investments n/a n/a 276.39M n/a 430K n/a n/a n/a n/a
Other Investing Acitivies -11.51M -75K -276.39M 172K 430K -40K -1.28M -19.67M -4.64M
Investing Cash Flow 15.81M -116.44M -283.76M -20.5M -7.91M -6.1M -60.19M -31.38M -11M
Debt Repayment -23.26M 59.62M 166.2M -10M -1.37M -5.25M -17.74M -4.25M 9.3M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a -367K -19.89M -9.14M -7.85M -1.02M -2.4M -2.5M
Other Financial Acitivies -4.17M -3.37M -1.88M 317K -448K -160K 50M n/a n/a
Financial Cash Flow -26.65M 62.08M 273.37M -29.57M -10.95M -13.26M 31.25M -6.64M 6.8M
Net Cash Flow 5.13M -67.38M 12.37M 22.32M 21.75M 25.67M -10.82M -24.34M -1.96M
Free Cash Flow 7.98M -25.06M 15.62M 51.13M 32.37M 39.13M 11.48M -5.72M -3.61M